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Cannabinoids have been shown to possess anticonvulsant properties in whole animal models 
of epilepsy. The present investigation sought to examine the effects of cannabinoid receptor 
activation on kainic acid (KA)-induced epileptiform neuronal excitability. Under urethane 
anesthesia, acute KA treatment (10 mg kg−1, i.p.) entrained the spiking mode of simultaneously 
recorded neurons from random ﬁ  ring to synchronous bursting (% change in burst rate). Injection 
of the high-afﬁ  nity cannabinoid agonist (-)-11-hydroxy-8-tetrahydrocannabinol-dimethyl-heptyl 
(HU210, 100 µg kg−1, i.p.) following KA markedly reduced the burst frequency (% decrease in 
burst frequency) and reversed synchronized ﬁ  ring patterns back to baseline levels. Pre-treatment 
with the central cannabinoid receptor (CB1) antagonist N-piperidino-5-(4-clorophenyl)-1-(2,4-
dichlorophenyl)-4-methyl-3-pyrazole-carboxamide (rimonabant, SR141716A 3 mg kg−1, i.p.) 
completely prevented the actions of HU210. The present results indicate that cannabinoids 
exert their antiepileptic effects by impeding pathological synchronization of neuronal networks 
in the hippocampus.
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between the neurons within the population (activity correlations) 
are created, single-unit ﬁ  re in phase, whereas spikes from outside 
the correlated network are out of phase (Abeles et al., 1993). The 
present study was aimed at investigating the effects of cannabi-
noid receptor activation on KA-induced bursting activity in the 
CA1 hippocampal layer of anesthetized rats. We employed multi-
ple simultaneous extracellular single-neuron recordings to physi-
ologically verify the antiepileptic actions of cannabinoids and to 
better delineate the dynamics of population discharge patterns 
underlying epilepsy.
MATERIALS AND METHODS
ANIMALS AND SURGICAL PROCEDURES
Male Sprague-Dawley rats (n = 13, Charles River Laboratories), 
weighing 300–350 g at the time of surgery were housed in groups 
of three in large plastic cages and maintained on a 12:12-h light–
dark cycle (lights on at 7:00 AM). Water and food were available 
ad libitum. All experiments were performed in accordance to UK 
Home Ofﬁ  ce regulations under project license 40/1955 and with 
NIH guidelines (publication 86–23). Animals were anesthetized 
with urethane (25% w/v in water) at a dose of 1.4 g kg−1 (i.p.) and 
mounted on a modiﬁ  ed Kopf 1730 stereotaxic apparatus.
RECORDING PROCEDURES
Recordings were made with a bundle of eight microwire electrodes 
(Formvar-coated stainless steel, 50-µm diameter; NBLabs, TX, 
USA), with a stainless steel ground electrode connected to a unity-
gain 8 channel J-type ﬁ  eld effect transistor headstage (NBLabs). 
Electrodes were stereotaxically positioned via ﬁ  ne micromanipula-
tor control over the hippocampus (−5.5 mm AP, 3.0 L relative to 
bregma and −2.2 DV from the brain surface) according to Paxinos 
INTRODUCTION
The appearance of epileptic seizures is commonly associated 
with aberrant hypersynchronization of large neuronal aggregates 
(Walker and Kullmann, 1999). One of the most commonly affected 
brain areas is the hippocampus, where several mechanisms underly-
ing pathological synchronization have been identiﬁ  ed (Miles and 
Wong, 1983). Such mechanisms include alterations in gap junc-
tional signaling (Jefferys, 1995), imbalances of excitatory/inhibitory 
currents (Cohen et al., 2002) and an enhancement of inhibitory 
GABAergic feedback (Haas et al., 1996). In the present study, hip-
pocampal epileptiform activity was induced pharmacologically 
with kainic acid (KA). This excitotoxin produces an episode of 
status epilepticus (Sokal and Large, 2001) and complex epileptiform 
EEG patterns (Ben-Ari, 1985; Medvedev and Willoughby, 1999) 
when administered acutely in vivo.
Available evidence from human and animal seizure models 
suggests that various cannabinoid compounds (derived from the 
marijuana plant, Cannabis sativa) have antiepileptic properties 
(Cunha et al., 1980; Wallace et al., 2002). Furthermore, ananda-
mide has been shown to modulate seizure threshold and severity 
through CB1 receptors implicating the endogenous cannabinoid 
system in epilepsy (Karanian et al., 2007). An earlier study by Hàjos 
et al. (2000) provided a mechanistic explanation for the effects of 
the endogenous cannabinoid receptor ligand anandamide. Using 
hippocampal slices, the authors showed that bath application of 
cannabinoid receptor agonists reduce the power of KA-induced 
network oscillations, these actions were prevented by pre-treatment 
with the CB1 receptor antagonist rimonabant.
Population studies provide valuable information in terms of 
temporal associations among recorded neurons and of speciﬁ  c fea-
tures of single-neuronal ﬁ  ring. As functional synaptic  correlations 
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and Watson (1986). The temperature of the animal was maintained 
at 37.7°C with the aid of a rectal probe connected to a homeother-
mic control unit (Harvard Apparatus, MA, USA). The second level 
of ampliﬁ  cation occurred at a 16-channel differential preampli-
ﬁ  er (ﬁ  xed gain ×100; Plexon Inc, TX, USA) after which the signal 
was transferred to a Multi-Channel Acquisition Processor (Plexon 
Inc, TX, USA). This allowed for computer-controlled ampliﬁ  ca-
tion, ﬁ  ltering, switching and digital signal processing of the signals 
originating from the microwires. The impedance of the electrodes 
was ∼300 kΩ measured at 1 kHz. Commercially available software 
(RASPUTIN; Plexon Inc, TX, USA) allowed on-line isolation and 
discrimination (using dual voltage–time widows or principal 
component analysis) of neuronal spikes from background noise. 
Typically, one to four action potential waveforms were observed 
and discriminated per microwire during any given experiment. 
Activity was also displayed on a Tektronix D11 5000 series dual-
beam oscilloscope and corresponding action potential waveforms 
were isolated with the aid of a Gould 1425 Digital Oscilloscope and 
a Gould Type 125 waveform processor. Firing rate was also moni-
tored aurally with the aid of a loudspeaker. Signals were ﬁ  ltered 
using a second order low cut-off (500 Hz) and high cut-off (5 kHz), 
with a 50-Hz notch ﬁ  lter. The gain block was a programmable gain 
multiplier with gain steps 1–30 (total gain: ×1000 to ×32,000); typi-
cally the gain was set at ×10,000 for the experiments.
PHARMACOLOGICAL MANIPULATIONS
HU210 was obtained from Tocris Cookson (UK, USA), KA was 
obtained from Sigma Chemical (UK, USA) and rimonabant 
(SR141716A) was a generous gift from Sanoﬁ  -Synthelabo. HU210 
and rimonabant were resuspended to stock concentration (10−2 M) 
in ethanol and refrigerated at −20°C. Drugs were dissolved in a 
physiological 1.0-ml saline (0.9% NaCl)/10-µl Tween 80 (1%) 
vehicle solution for injection on the day of the experiment. KA 
was resuspended to stock concentration (10−2 M) in distilled water 
and frozen (−20°C) in 200-µl aliquots. When required, the aliquots 
were thawed and diluted in 0.2-ml saline and for each experiment 
an aliquot was thawed and diluted in 0.2-ml saline to the desired 
dose. All drugs were injected intraperitoneally (i.p.).
ELECTROPHYSIOLOGICAL ANALYSES
Discriminated single-unit data was initially visualized off-line as 
spike rasters; the spike raster representing action potential spikes, 
viewed as vertical ticks, corresponding to the temporal (time 
stamped) occurrence of the spikes. Data was subsequently ana-
lyzed as integrated ﬁ  ring rate histograms (accumulated over 5 or 
10 s epochs); burst analyses were calculated for epochs of 15 s dur-
ing periods of bursting activity and cross-correlation histograms 
(CCHs; Gerstein, 1970), between pairs of hippocampal neurons, 
were computed using NeuroExplorer (Plexon Inc, TX, USA). Basal 
activity was calculated as the mean ± SEM of ﬁ  ring during a selected 
10-min pre-drug period for overall ﬁ  ring analyses and over 15 s 
for burst analyses. Visual evaluation of bursting discharge activ-
ity, induced by KA injection, in the spike raster displays revealed 
two types of neuronal discharge – “micro-bursts” and “macro-
bursts”. Micro-bursts were empirically deﬁ  ned as follows: maxi-
mum burst start interval of 170 ms, maximum interspike interval 
within the burst 300 ms; minimum inter-burst interval 200 ms; 
minimum duration for a burst 100 ms and minimum number of 
spikes within a burst, minimum of three spikes. Macro-bursts were 
much slower oscillations in overall ﬁ  ring (clearly visible over longer 
time frames – see Figure 3A) with a periodicity of 180–220 s. CCH 
analysis (Figure 1B) shows the conditional probability of the occur-
rence of a spike in the spike train at time t on the condition that 
there is a reference event (or reference spike; in this case spikes from 
neuron 1) at time 0 (Gerstein, 1970). Therefore, if the graph shows 
a ﬂ  at proﬁ  le, neurons are not ﬁ  ring synchronously with respect to 
a given reference neuron. Correlated discharge activity (i.e., func-
tional ﬁ  ring synchronicity) between pairs of neurons were revealed 
in CCHs as a central peak (or trough) centered on the zero time bin, 
while a ﬂ  at cross-correlation indicated non-correlated discharge 
activity between neuronal pairs (Eblen-Zajjur and Sandkuhler, 
1997). Conventional analyses of variance (ANOVA) were used to 
study treatment–response differences. The Scheffé’s post-hoc test 
was used to assess differences between and within treatments. The 
criterion of signiﬁ  cance for the ANOVAs and post-hoc tests was 
set at p < 0.05. All data are expressed mean ± SEM and statistical 
analyses were computed using Statistica (Statsoft Inc, OK, USA).
On completion of experiments, the location of the recording 
electrode tips was marked by passing a 60-µA current for 30 s 
through electrode pairs in the array. Animals were then transcar-
dially perfused with a 4% paraformaldehyde/5% potassium ferro-
cyanide solution. Ferrocyanide creates a blue-green stain by reacting 
with deposited iron ions at the mark site. The brains were then 
removed and stored at 4°C in the same ﬁ  xative solution overnight. 
Vibratome sections were then cut (80 µm) and transferred to slides 
with the aid of mounting medium (Vectashield). Photographic 
images were made using a low power objective without further 
counter-staining of the sections.
RESULTS
A total of 58 neurons (n = 6 rats) were recorded showing action 
potential signal-to-noise amplitude ratios of at least a 3:1. KA 
(10 mg kg−1) produced a signiﬁ  cant increase in the number of 
bursts over pre-drug activity in 46 of 58 units from 4.1 ± 1.06 to 
10.5 ± 1.18 bursts (Figures 1A and 2; F(1,57) = 15.74, p < 0.0008). 
Every neuron studied was signiﬁ  cantly (p < 0.05) excited from pre-
drug basal ﬁ  ring following KA injection (Figure 3; 6.89 ± 1.18 to 
13.05 ± 2.04 Hz, for the entire population). The onset latency for 
KA observable effects was ∼6 min after injection.
Inspection of ﬁ  ring rate histograms showed that KA treatment 
elicited two types of bursts: micro-bursts (as deﬁ  ned in “Materials 
and methods”) and macro-bursts that lasted ∼202 ± 21.2 s in dura-
tion (Figure 3A). The number of KA-induced micro-burst events was 
signiﬁ  cantly reduced by the high-afﬁ  nity cannabinoid agonist HU210 
from 10.5 ± 1.18 to 3.55 ± 2.07 bursts during each analysis period 
(Figures 1 and 2; F(1,57) = 8.89, p < 0.05). The KA-induced elevation in 
ﬁ  ring rate was only marginally reduced by concurrent administration 
of HU210 (100 µg kg−1), decreasing the ﬁ  ring rate of simultaneously 
recorded neurons from 13.05 ± 2.04 to 10.74 ± 1.56 Hz on this short 
time scale (F(2,85) = 1.1, p < 0.38, data not shown). The frequency of 
macro-bursts was similarly inhibited (Figure 3) by HU210 from 
3.7 ± 1.1 to 1.1 ± 0.3 bursts (F(1,57) = 3.2, p < 0.05, data not shown); 
however on this longer time scale, overall ﬁ  ring rate was signiﬁ  cantly 
reduced 11.15 ± 3.04 to 4.84 ± 2.26 (F(2,85) =  8.4, p < 0.05).Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 13  |  3
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FIGURE 1 | Cannabinoids reverse kainate-induced epileptiform-like activity 
in the hippocampus. (A) Representative spike rasters for nine simultaneously 
recorded neurons showing activity during pre-drug basal ﬁ  ring (upper panel) and 
the induction of synchronous burst ﬁ  ring induced by kainate (KA; 10 mg kg−1; 
middle panel). HU210 (100 µg kg−1) reversed the KA-induced synchronous 
activity to that seen during basal activity. (B) Representative cross-correlation 
histogram (CCH) analyses (with auto-correlogram for neuron 1) for the same 
neurones shown in the raster displays above. CCHs again illustrate KA-induce 
synchronous activity and its reversal by HU210. CCH reference was neuron 1 
(time 0); bin width 1 ms. All doses i.p.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 13  |  4
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FIGURE 3 | Modulation of KA-induced slow oscillations in ﬁ  ring by CB1 
receptors. (A) Representative integrated ﬁ  ring rate histograms (bin width 
10 s) illustrating KA-induced macro-burst ﬁ  ring pattern (periodicity ∼200 s). 
Injection of HU210 abolished this slow oscillatory ﬁ  ring activity. (B) Pre-
treatment with the CB1 antagonist rimonabant (SR) completely blocked the 
actions of HU210. Arrow heads indicate the time of HU210 (100 µg kg−1) or 
rimonabant (3 mg kg−1) injections during KA (10 mg kg−1). All doses i.p.
Cross-correlation histogram analyses conﬁ  rmed  the  visual 
inspection of the raster displays that there is limited or no syn-
chronous activity between hippocampal neurons during pre-drug 
basal activity, at least under the recording conditions of the present 
experiments (Figure 1B). Following KA injection, corresponding 
with the period of KA-induced micro-burst and macro-burst 
activity, there was development of synchronous activity, revealed 
by peaks in the CCHs around time bin 0 (Figure 1B). This was 
reversed by injection of HU210, resulting in CCHs showing a ﬂ  at 
proﬁ  le similar to that expressed under basal conditions (Figure 1B), 
indicative of non-synchronous activity.
The observed antiepileptic effects on hippocampal cell activity 
are mediated by CB1 receptors as the number of KA-induced micro-
bursts was not signiﬁ  cantly different from KA alone (9.98 ± 3.21; 
F(2,77) = 4.3, p < 0.69) when HU210 was injected in the presence of 
the CB1 receptor antagonist rimonabant (21 neurons, n = 3 rats, 
3 mg kg−1, Figure 2). Pre-treatment with rimonabant (3 mg kg−1) 
also prevented the blockade of KA-induced changes in ﬁ  ring rate 
and bursting activity patterns by HU210, whilst being devoid of 
effects of its own (5.81 ± 2.38 Hz during KA/SR and 7.01 ± 3.13 Hz 
during KA/SR/HU210, and 9.1 ± 1.13 total bursts during KA/SR 
and 11.24 ± 4.28 total bursts during KA/SR/HU210, F(2,77) = 8.1, 
p < 0.34, Figure 3).
DISCUSSION
The present in vivo multiple single-unit study has generated 
two main ﬁ  ndings. First, functionally cross-correlated epilepti-
form-like population activity can be evoked by the non-NMDA 
receptor agonist KA in the hippocampal CA1 pyramidal layer of 
urethane-anesthetized rats, in a way reminiscent of epileptiform-
like activity observed in hippocampal dissociated and organotypic 
cultures (Jagger et al., 2001, 2002; Roe and Mason, 2002; Sokal 
et al., 2000). The excitotoxin injection increased the ﬁ  ring rate of 
all the recorded neurons and also increased the burst frequency 
in the majority of simultaneously recorded cells whilst entraining 
them to a synchronized ﬁ  ring mode (no KA-induced inhibitions 
of ﬁ  ring were observed). Secondly, when injected in the presence of 
KA, the potent CB1 receptor agonist HU210 signiﬁ  cantly reduced 
the elevation in burst rate (accompanied by a modest reduction 
in overall ﬁ  ring rate) elicited by KA treatment accompanied by a 
reversal of synchronized burst ﬁ  ring to random activity.
The hippocampal formation is one of the most seizure-prone 
structures in the brain due to its deﬁ   ning characteristic; the 
presence of a tri-synaptic circuit of ﬁ  bers. The reverberation of 
impulse activity in the hippocampal loop is suggested to cause 
and maintain epileptiform-like activity (Stringer and Lothman, 
1992). Hippocampal cells are endowed with several voltage and 
ligand-gated conductances, which play a major role in the cells’ 
excitability. Even under normal basal conditions cells produce burst 
discharges that are qualitatively similar to epileptiform-like activity. 
Blockade of GABAergic transmission has been consistently proven 
to precipitate seizures. It has thus been assumed that abnormal 
GABAergic neurotransmission may be related to epilepsy (Prince, 
1978). Accordingly, the most common pharmacological manipula-
tion to cause neuronal disinhibition is the use of the convulsant 
alkaloid bicuculline; a GABAA receptor antagonist (Margineanu and 
Wülfert, 1999). However, in vivo epilepsy can also be induced with 
exposure to toxins or direct brain electrical stimulation, in a manner 
that may not be directly related to GABAergic mechanisms. One 
such agent is the excitotoxin KA, an AMPA/kainate receptor ago-
nist. KA-induced seizures are a well-established model of  temporal 
FIGURE 2 | Incidence of mean burst rate (bursts per analysis 
epoch ± SEM) as a function of drug treatment. KA signiﬁ  cantly increased 
the burst frequency from pre-drug basal activity and entrained the network to 
burst synchronously. Co-application of the CB1 receptor agonist HU210 (HU) 
signiﬁ  cantly decreased burst rate and disrupted the synchronicity in ﬁ  ring 
induced by KA. When injected in the presence of the CB1 receptor antagonist 
rimonabant (SR), HU210 did not alter KA-induced synchronous bursting 
activity (**p < 0.01; ***p < 0.005 vs baseline and &&p < 0.01 vs KA-induced 
bursting).Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 13  |  5
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lobe epilepsy and epileptic seizures reliably occur at the chosen 
systemic dose of 10 mg kg−1 used in this study, a non-toxic dose 
(Sperk, 1994). Interestingly, Khazipov and Holmes (2003) elegantly 
implicated GABA inhibitory mechanisms in the emergence of syn-
chronized epileptiform-like activity elicited by KA. In their in vivo 
superfused hippocampus preparation, GABAA   receptor-mediated 
currents coincided with the inhibition of neuronal ﬁ  ring as assessed 
by the cross-correlogram of spikes vs inhibitory postsynaptic cur-
rents. The authors found that when inhibitory currents ceased, 
the probability of ﬁ  ring of pyramidal cells increased. Mediation of 
GABAA receptors was further conﬁ  rmed by the ﬁ  nding that bicucul-
line perfusion suppressed KA-induced oscillations.
The hippocampus is one of the areas with the highest cannabi-
noid receptor binding densities in the rat brain (Herkenham et al., 
1991). This structure also exhibits the highest concentrations of 
both anandamide (Felder et al., 1996) and 2-  arachidonylglycerol 
(Stella et al., 1997), the two most abundant endogenous can-
nabinoid ligands. It is now well accepted that presynaptic CB1 
receptors are located on the terminals of cholecystokinin (CCK+)-
  containing GABAergic interneurons to inhibit Ca2+ dependent 
GABA release via N-type channels (for review see Freund et al., 
2003). Cannabinoid receptors are also reported to be situated on 
glutamatergic presynaptic terminals inhibiting glutamate release 
via terminal N-type and P/Q type Ca2+ channels (Twitchell 
et al., 1997) in autaptic circuits as well as in hippocampal slices 
(Kawamura et al., 2006). Thus, at least in the hippocampus, CB1 
receptors are located on (CCK+) basket and dendritically project-
ing cells (Freund, 2003; Hàjos et al., 2000) as well as on excitatory 
afferents to pyramidal cells (Takahashi and Castillo, 2006). We 
are therefore left with the view that mixed actions of HU210 on 
inhibitory and excitatory neurotransmission are responsible for 
reversing synchronized burst ﬁ  ring. Since intact GABAergic inhi-
bition is necessary for the maintenance of KA-induced bursting, 
the activation of CB1 receptors by HU210 on the terminals of 
different populations of GABAergic neurons in the hippocampus 
and the corresponding inhibition of GABAA synaptic inhibition 
(Hoffman and Lupica, 2000) could be sufﬁ  cient to shunt synchro-
nous population bursting. However, direct effects of CB1 agonists 
in suppressing glutamatergic excitatory neurotransmission have 
been observed in a KA model of seizure (Monory et al., 2006). This 
suggests CB1 receptors are also critically involved in the control 
of excitatory glutamatergic neurotransmission. Thus, activation 
of CB1 receptors may therefore confer inhibitory effects via sup-
pression of excitatory synapses under hyperexcitable conditions. 
Nevertheless, because of the systemic nature of the dosing regimen 
employed in our study, contributions from outside the hippoc-
ampal circuitry cannot be ruled out (microinjection studies are 
currently ongoing in our laboratory to address this issue).
The ﬁ  nding that the CB1 receptor antagonist rimonabant was 
devoid of effect on KA-induced synchronized bursting is puz-
zling (but see Robbe et al., 2006) since the present KA manipula-
tions represent the ideal conditions for the on-demand release 
of endocannabinoids hippocampal slices. This may indicate that 
the basal level of endocannabinoid binding to CB1 receptors is 
not sufﬁ  cient to effectively modulate epileptiform-like activity in 
anesthetized animals by virtue of achieving a ceiling effect wit 
the dose of KA used here. It would be interesting to determine 
whether an effect of rimonabant would be uncovered when record-
ing are performed in awake, freely-moving rats. It would also be 
important to determine whether injection of rimonabant prevents 
the induction of   epileptiform-like activity by KA, since it does 
not reverse KA effects on its own. Nevertheless, the present study 
replicates and builds upon previous ﬁ  ndings that KA-induced 
increases in ﬁ  ring and burst ﬁ  ring rates are attenuated by inhibi-
tion of anandamide (an endocannabinoid) hydrolysis (Coomber 
et al., 2008). However, under those conditions rimonabant only 
partly diminished the effects of anandamide hydrolysis blockade 
(in that particular study functional connectivity was not assessed). 
The appearance of “macro-bursts” composed of “micro-bursts” in 
the present report could be associated with metabolic recovery fol-
lowing intense increases in ﬁ  ring rate. Alternatively, the extensive 
calcium inﬂ  ux during periods of sustained elevated activity may 
sequentially trigger downregulation of inhibitory and/or excita-
tory processing (see Hàjos and Freund, 2002) and the generation 
of the subsequent volley of intense ﬁ  ring.
These previously unseen ﬁ  ndings suggest that the reduction in 
spike timing coordination and the associated decrease in hippocam-
pal population activity are important in the well- documented antie-
pileptic actions of cannabinoid compounds (Smith, 2005). A major 
implication of these data is that the synchrony of spike timing in 
neuronal assemblies is a critical component of   epileptiform-like 
activity in vivo. The effect of cannabinoids on network dynamics 
is noteworthy because neurons form assemblies deﬁ  ned by syn-
chronous action potential ﬁ  ring and these changes in population 
synchronicity are thought to accompany status epilepticus (Williams 
et al., 2007).
In conclusion we have shown that cannabinoid receptors modu-
late the rhythmicity and synchronization generated by inhibitory 
neuronal networks in the rat hippocampus. Further investigations 
are required to determine the clinical relevance and the site of action 
of the cannabinoid agonist, since drugs that reduce synchronization 
may represent novel anticonvulsants.
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